Article: [RS3PE syndrome with angioimmunoblastic T-cell lymphoma early after the start of immunosuppressive therapy].
Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics
2023 Volume 60, Issue 1, Page(s) 60–66
Abstract: A 75-year-old man visited our Collagen Disease Department because of a fever, edema in the lower legs, and arthralgia. He presented with peripheral arthritis of the extremities and was negative for rheumatoid factor, leading to a diagnosis of RS3PE ... ...
| Abstract | A 75-year-old man visited our Collagen Disease Department because of a fever, edema in the lower legs, and arthralgia. He presented with peripheral arthritis of the extremities and was negative for rheumatoid factor, leading to a diagnosis of RS3PE syndrome. A search for malignancy was performed, but no obvious malignant findings were found. After starting treatment with steroid, methotrexate, and tacrolimus, the patient's joint symptoms improved, but after five months, enlarged lymph nodes throughout the body were observed. A lymph node biopsy revealed a diagnosis of other iatrogenic immunodeficiency-associated lymphoproliferative disorders/angioimmunoblastic T-cell lymphoma (OI-LPD/AITL). After discontinuation of methotrexate and follow-up, no lymph node shrinkage was observed, and the patient had strong general malaise, so chemotherapy was started for AITL. After the start of chemotherapy, the patient's general symptoms improved quickly. RS3PE syndrome is a polyarticular, rheumatoid factor-negative, polyarticular synovitis with symmetric dorsolateral hand-palmar symmetric indentation edema that occurs mainly in elderly patients. It is also noted as a paraneoplastic syndrome, with 10%-40% of patients having malignant tumors. When our patient was diagnosed with RS3PE syndrome, a search for malignancy was performed, but there were no findings suggestive of malignant disease. However, after methotrexate and tacrolimus administration was started, the patient developed rapid lymph node enlargement, and the pathology showed AITL. The possibility of AITL as an underlying disease and RS3PE syndrome as a paraneoplastic syndrome, or conversely, OI-LPD/AITL associated with immunosuppressive therapy for RS3PE syndrome is considered. We herein report this case, as sufficient recognition is required for a proper diagnosis to be made and treatment of RS3PE syndrome to be performed. |
|---|---|
| MeSH term(s) | Male ; Humans ; Aged ; Methotrexate ; Rheumatoid Factor ; Tacrolimus/therapeutic use ; Immunoblastic Lymphadenopathy/complications ; Immunoblastic Lymphadenopathy/drug therapy ; Immunoblastic Lymphadenopathy/pathology ; Paraneoplastic Syndromes/complications ; Paraneoplastic Syndromes/diagnosis ; Edema/complications ; Edema/diagnosis ; Lymphoma, T-Cell/complications ; Lymphoma, T-Cell/drug therapy ; Immunosuppression Therapy |
| Chemical Substances | Methotrexate (YL5FZ2Y5U1) ; Rheumatoid Factor (9009-79-4) ; Tacrolimus (WM0HAQ4WNM) |
| Language | Japanese |
| Publishing date | 2023-02-27 |
| Publishing country | Japan |
| Document type | Case Reports ; English Abstract ; Journal Article |
| ZDB-ID | 604107-3 |
| ISSN | 0300-9173 |
| ISSN | 0300-9173 |
| DOI | 10.3143/geriatrics.60.60 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
| Zs.A 1039: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.